Get the latest Science News and Discoveries
Evolocumab to reduce first major cardiovascular events in patients without known significant atherosclerosis and with diabetes - EurekAlert!
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.
None
Or read this on Eureka Alert